Have you ever faced challenges in the development and optimization of dry powder inhaler formulations? How did you address them?

Sample interview questions: Have you ever faced challenges in the development and optimization of dry powder inhaler formulations? How did you address them?

Sample answer:

Challenges Encountered:

  • Particle size and morphology control: Achieving optimal particle size distribution and morphology is crucial for inhalation performance. I addressed this by employing advanced techniques such as spray drying, supercritical fluid extraction, and mechanical attrition to tailor particle properties.

  • Drug stability: Dry powder inhaler formulations are susceptible to degradation over time. I implemented various strategies to enhance stability, including the use of protective excipients, encapsulation technologies, and optimization of storage conditions.

  • Delivery efficiency: Ensuring high pulmonary deposition efficiency is paramount. I employed computational models and in vitro characterization techniques to optimize particle characteristics and device design for optimal drug delivery to the target site.

  • Moisture sensitivity: Dry powder inhalers can be sensitive to moisture, affecting their performance and stability. I developed moisture-resistant formulations using desiccants, protective coatings, and vapor-impermeable packaging materials.

  • Excipient interactions: Understanding and mitigating interactions between drug and excipients is essential. I utilized advanced analytical techn… Read full answer

    Source: https://hireabo.com/job/5_2_16/Pharmaceutical%20Chemist

Leave a Reply

Your email address will not be published. Required fields are marked *